|
PPP5C expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.68769999999907E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.18629999998643E-06 |
| Normal-vs-Stage2 |
1.636600E-03 |
| Normal-vs-Stage3 |
2.632100E-02 |
| Normal-vs-Stage4 |
8.377800E-02 |
| Stage1-vs-Stage2 |
9.619200E-01 |
| Stage1-vs-Stage3 |
1.588590E-01 |
| Stage1-vs-Stage4 |
3.535800E-01 |
| Stage2-vs-Stage3 |
3.201400E-01 |
| Stage2-vs-Stage4 |
4.240400E-01 |
| Stage3-vs-Stage4 |
9.955600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.17639999999997E-05 |
| Normal-vs-AfricanAmerican |
5.770700E-04 |
| Normal-vs-Asian |
1.237580E-01 |
| Caucasian-vs-AfricanAmerican |
6.876400E-01 |
| Caucasian-vs-Asian |
7.417800E-01 |
| AfricanAmerican-vs-Asian |
8.478600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.26940000025833E-07 |
| Normal-vs-Female |
3.495900E-02 |
| Male-vs-Female |
1.282600E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.793800E-04 |
| Normal-vs-Extreme_Weight |
1.61990000002721E-06 |
| Normal-vs-Obese |
1.289800E-02 |
| Normal-vs-Extreme_Obese |
1.249830E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.999000E-01 |
| Normal_Weight-vs-Obese |
2.981400E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.675400E-01 |
| Extreme_Weight-vs-Obese |
3.738200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.648000E-01 |
| Obese-vs-Extreme_Obese |
4.736200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.294200E-01 |
| Normal-vs-Age(41-60Yrs) |
2.023700E-03 |
| Normal-vs-Age(61-80Yrs) |
8.27239999945384E-07 |
| Normal-vs-Age(81-100Yrs) |
1.774660E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.400790E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.761000E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.200400E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.012390E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.811600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.538400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.181000E-04 |
| Normal-VS-Type2 PRCC |
8.90549999965629E-07 |
| Normal-VS-KIRP CIMP |
1.103820E-01 |
| Normal-VS-Unclassified PRCC |
5.896000E-03 |
| Type1 PRCC-VS-Type2 PRCC |
4.076500E-02 |
| Type1 PRCC-VS-KIRP CIMP |
6.305800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.787800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.549190E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.668220E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.758200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.58931999999501E-05 |
| Normal-vs-N1 |
8.298500E-02 |
| Normal-vs-N2 |
4.235900E-02 |
| N0-vs-N1 |
4.656000E-02 |
| N0-vs-N2 |
8.460400E-01 |
| N1-vs-N2 |
3.342000E-01 |
|
|
